SCHEMBL13320342

SCHEMBL13320342

Cc1ccc2c(c1)c(-c1ccc3ncccc3c1)cc1c3ccc(C)c4c3c(cc21)-c1ccccc1-4

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41
DYRK1A Q13627 1/20 0.38
ADORA2A P29274 2/20 0.37
SRC P12931 4/20 0.36
KDR P35968 3/20 0.36
PIK3CD O00329 2/20 0.36
ABL1 P00519 2/20 0.36
EGFR P00533 2/20 0.36
HCK P08631 2/20 0.36
PIK3CA P42336 2/20 0.36
PIK3CB P42338 2/20 0.36
MTOR P42345 2/20 0.36
PIK3CG P48736 2/20 0.36
EPHB4 P54760 2/20 0.36
PRKDC P78527 2/20 0.36
AR P10275 1/20 0.36
BACE1 P56817 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13320352 0.92 ALDH1A1 (0.45) ALDH1A1ADORA2ABACE1CTSDKDM4E
SCHEMBL4746018 0.91 ALDH1A1 (0.44) ALDH1A1NPC1POLBRAB9ADYRK1A
SCHEMBL13320339 0.87 CYP1A2 (0.39) ALDH1A1NPC1POLBRAB9ASRC
SCHEMBL4745812 0.83 ALDH1A1 (0.34) ALDH1A1ADORA2ASRCKDRPIK3CD
SCHEMBL4746016 0.83 HSP90AA1 (0.37) ALDH1A1NPC1RAB9ADYRK1ASRC
SCHEMBL4746019 0.82 ALDH1A1 (0.44) ALDH1A1ADORA2AMAPK14MEN1KMT2A
SCHEMBL13320347 0.82 CCR1 (0.39) ALDH1A1KDRKDM4EMAPTMEN1
SCHEMBL13320354 0.82 CA12 (0.37) ALDH1A1KDR
SCHEMBL4746389 0.82 DHODH (0.34) ALDH1A1NPC1RAB9AABL1BACE1
SCHEMBL13320366 0.81 TDO2 (0.41) ALDH1A1POLBSRCKDRPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431244-B2 Indenochrysene derivative and organic light-emitting device using same CANON KABUSHIKI KAISHA (JP) 2013-04-30 US disclosed
US-8431244-B2 Indenochrysene derivative and organic light-emitting device using same CANON KABUSHIKI KAISHA (JP) 2013-04-30 US disclosed
US-20100127618-A1 INDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING SAME CANON KABUSHIKI KAISHA (JP) 2010-05-27 US disclosed
US-20100127618-A1 INDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING SAME CANON KABUSHIKI KAISHA (JP) 2010-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100127618-A1 INDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING SAME OR51E2, INTS9, ORAI2 ALDH1A1 63/4885NPC1 2765/4885POLB 2587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.